Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 6/2000

01-10-2000

Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice

Authors: R. Moats, L.Q. Ma, R. Wajed, Y. Sugiura, A. Lazaryev, M. Tyszka, R. Jacobs, S. Fraser, M.D. Nelson Jr., Y.A. DeClerck

Published in: Clinical & Experimental Metastasis | Issue 6/2000

Login to get access
Metadata
Title
Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice
Authors
R. Moats
L.Q. Ma
R. Wajed
Y. Sugiura
A. Lazaryev
M. Tyszka
R. Jacobs
S. Fraser
M.D. Nelson Jr.
Y.A. DeClerck
Publication date
01-10-2000
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 6/2000
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1011827122126

Other articles of this Issue 6/2000

Clinical & Experimental Metastasis 6/2000 Go to the issue

OriginalPaper

Partial purification of a liver-derived tumor cell growth inhibitor that differentially inhibits poorly-liver metastasizing cell lines: Identification as an active subunit of arginase

OriginalPaper

Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma

OriginalPaper

Organ-specificity of the extravasation process: An ultrastructural study

OriginalPaper

TGFβ1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103

OriginalPaper

The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior

OriginalPaper

Expression of angiogenesis-related genes in ovarian carcinoma – A clinicopathologic study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits